Pavella Therapeutics raises target price to $232 from $210
PVLA•Oppenheimer raised its target price for Pavella Therapeutics to $232 from $210.
Related News
Susquehanna cuts MACOM Technology Solutions target price to $220 from $300
MTSI•
Planet Fitness target price raised to $72 from $62 by Raymond James
PLNT•
Aurelion forms digital asset management committee
AURE•
Evolent Health: Oppenheimer raises target price to $7 from $6
EVH•
Draganfly publishes update to financial calendar
DPRO•